Important Note: Redirection of Services to ChiCTR
We would like to inform you that the Clinical Trial Registry page will discontinue the function of updating trial information directly on this platform. However, you will still be able to view the existing registration details. For any updates to trial information, you can use the China Clinical Trial Registry (ChiCTR) directly at https://www.chictr.org.cn. This change will be fully implemented by 2024-Aug-05. Thank you for your attention.
CUHK_CCT00450
2015-03-26
Prospective
CREC 2014.207-T
investigator initiated study
Divison of Family Medicine and Primary Health Care, The Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong
Dr Regina Wing Shan SIT
nil
Wing Yin TAM
Room 04, 4/F, Lek Yuen Health Centre, 9 Lek Yuen Street, Shatin, N.T., Hong Kong
25039053
wingyintam@cuhk.edu.hk
The Chinese University of Hong Kong
Dr Regina Wing Shan SIT
Room 17A, 4/F, Lek Yuen Health Centre, 9 Lek Yuen Street, Shatin, N.T., Hong Kong
25039053
reginasit@cuhk.edu.hk
The Chinese University of Hong Kong
Efficacy of hypertonic dextrose prolotherapy in the treatment of temporomandibular dysfunction with: A randomized controlled clinical trial
Efficacy of hypertonic dextrose prolotherapy in the treatment of temporomandibular dysfunction
葡萄糖注射對顳顎關節障礙的治療成效
Dextrose injection to temporomandibular joint
Hong Kong
Yes
2014-05-07
Temporomandibular dysfunction
Procedure
1 ml 20% dextrose with 0.2% lidocaine
13 weeks
1 ml of normal saline with 0.2 % lidocaine
-adults ≥ 18 years old who complain of pain in the face for more than 6 months and have at least one of the following symptoms referable to the jaw:
difficulty chewing
stiffness in the jaw
tension in the jaw
fatigue with eating or grinding of teeth
-All the recruited participants should have their average numerical rating scale (NRS) > 5 for both facial pain and jaw dysfunction in the past 6 months
- Previous jaw operation
- Pregnancy
- Patients on anti-coagulant therapy
- Prior TMJ prolotherapy
- AnyTMJ injections within 3 months
- Co-morbidity severe enough to prevent participation in the study protocol like attendance at scheduled injection appointments
- Unable to understand or to give consent
18
75
Both Male and Female
Interventional
Randomized
Placebo
Double-blind
Parallel
2015-07-01
40
Not Yet Recruiting
Nurmerical rating scale (NRS) in the face and the NRS for jaw dysfunction at week 1, week 13 and at 1 year.
The secondary outcome will be the change in maximal mouth opening (MMO) in centimeter and “end feel” of the TMJ (hard or soft).
2018-04-09
ChiCTR-IOR-15006158
2015-03-28
Yes
not applicable
|
|
|
|
|
---|---|---|---|---|
No documents yet. |